Physician profile
Robert R Pollard
NPI 1184792525
$16,219.64
in general payments reported to CMS, 2019-2025
13 companies · $8,115 in 2025
The $8,115 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,189 · 2020: $496 · 2021: $246 · 2022: $1,571 · 2023: $912 · 2024: $1,691 · 2025: $8,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $3,479 · Food and Beverage: $2,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $3,479.37 |
| Food and Beverage | $2,738.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,717.03 | 2019-2025 | |
| Caldera Medical, INC | $3,815.16 | 2019-2024 | Desara |
| Boston Scientific Corporation | $884.46 | 2019-2025 | Advantage System, Upsylon |
| Northgate Technologies, INC. | $600.00 | 2022 | |
| Medtronic, INC. | $590.68 | 2022-2024 | Ligasure, Interstim |
| Axonics, INC. | $523.37 | 2022-2024 | Axonics, Bulkamid |
| Coloplast Corp | $318.70 | 2020-2024 | |
| Medtronic USA, INC. | $166.49 | 2019-2020 | |
| Davol INC. | $157.64 | 2024 | Arista Ah Flexitip |
| Bluewind Medical | $123.46 | 2025 | Revi |
| Allergan, INC. | $114.14 | 2019 | |
| Coopersurgical, INC. | $108.75 | 2022-2023 | Summit Doppler |
| Abbvie INC. | $99.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pollard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.